Auster Martin's Form 4 filing
Ventyx Biosciences, Inc. (VTYX) · filed Apr 27, 2023
- Accession no.
- 0001209191-23-025876
- Filed
- Apr 27, 2023
- Trade date
- Apr 25, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.06M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Auster MartinCIK 0001875786 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 25, 2023 | Common Stock | MOption exerciseAcquired | +28,000 | $3.45 | +$96,600 | 75,649 | Direct | |
| Apr 25, 2023 | Common Stock | SSaleDisposed | −18,748 | $37.55F2 | −$703,987.4 | 56,901 | Direct | |
| Apr 25, 2023 | Common Stock | SSaleDisposed | −4,262 | $38.76F3 | −$165,195.12 | 52,639 | Direct | |
| Apr 25, 2023 | Common Stock | SSaleDisposed | −4,990 | $39.23F4 | −$195,757.7 | 47,649 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 25, 2023 | Common Stock | MOption exerciseDisposed | −28,000 | $0.00 | $0 | 275,184 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average share price of an aggregate total of 18,748 shares sold in the price range of $37.05 to $38.035. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average share price of an aggregate total of 4,262 shares sold in the price range of $38.055 to $39.055. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average share price of an aggregate total of 4,990 shares sold in the price range of $39.06 to $39.8098. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.